Noteworthy, both chemotherapy drugs reported to stimulate, and not stimulate, immunogenic cell death (ICD) similarly increased COX-2 expression and PGE2 synthesis, excluding this phenomenon as major contributor to the differential ability of ICD and non-ICD inducers to stimulate cancer immunity. This evidence concerns the gene PTGS2 and cancer.